Terry A Jacobson MD

School/Division:

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 19

  1. 1
  2. 2

Article

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT

by Terry Jacobson; S Selvaraj; DL Bhatt; PG Steg; M Miller; EA Brinton; RA Juliano; L Jiao; JC Tardif; CM Ballantyne

2022

Article

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI

by Benjamin E. Peterson; Deepak L. Bhatt; Ph. Gabriel Steg; Michael Miller; Eliot A. Brinton; Terry Jacobson; Steven B. Ketchum; Rebecca A. Juliano; Lixia Jiao; Ralph T. Doyle Jr; Craig Granowitz; C. Michael Gibson; Duane Pinto; Robert P. Giugliano; Matthew J. Budoff; Jean-Claude Tardif; Subodh Verma; Christie M. Ballantyne

2022

Article

Effect of a Pharmacist Intervention on Clinically Important Medication Errors after Hospital Discharge: A Randomized Controlled Trial

by Sunil Kripalani; Christianne L. Roumie; Anuj K Dalal; Courtney Cawthon; Alexandra Businger; Sveltlana Eden; Ayumi Shintani; Kelly Cunningham Sponsler; L. Jeff Harris; Cecelia Theobald; Robert L. Huang; Danielle Scheurer; Susan Hunt; Terry A Jacobson; Kimberly J Rask; Viola Vaccarino; Tejal K Gandhi; David W Bates; Mark V. Williams; Jeffrey Schnipper

2012

Article

REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results

by Terry Jacobson; B Olshansky; DL Bhatt; M Miller; PG Steg; EA Brinton; SB Ketchum; RT Doyle Jr; RA Juliano; L Jiao; C Granowitz; J-C Tardif; C Mehta; R Mukherjee; CM Ballantyne; MK Chung

2021

Article

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment

by William Weintraub; Terry Jacobson; DL Bhatt; Z Zhang; S Dolman; WE Boden; AP Bress; JB King; BK Bellows; GS Tajeu; CG Derington; J Johnson; K Andrade; PG Steg; M Miller; EA Brinton; J-C Tardif; CM Ballantyne; P Kolm

2022

Article

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL

by Terry Jacobson; A Majithia; DL Bhatt; AN Friedman; M Miller; PG Steg; EA Brinton; SB Ketchum; RA Juliano; L Jiao; RT Doyle; C Granowitz; M Budoff; RP Mason; J-C Tardif; WE Boden; CM Ballantyne

2021

Article

Health Literacy and the Quality of Physician-Patient Communication During Hospitalization

by Sunil Kripalani; Terry Jacobson; C. Ileko Mugalla; R. Courtney Cawthon; Kurt J. Niesner; Viola Vaccarino

2010

Article

Reduction in Revascularization With Icosapent Ethyl Insights From REDUCE-IT Revascularization Analyses

by Terry Jacobson; BE Peterson; DL Bhatt; PG Steg; M Miller; EA Brinton; SB Ketchum; RA Juliano; L Jiao; RT Doyle; C Granowitz; CM Gibson; D Pinto; RP Giugliano; MJ Budoff; J-C Tardif; S Verma; CM Ballantyne

2021